Drug Industry Daily
Oct. 10, 2012
| Vol.
11 No.
199
Specification Concerns Prompt Recall, MHRA Alert on Sanofi Pasteur Typhoid Vaccine
Sanofi Pasteur MSD, a Merck-Sanofi vaccine venture, is recalling 16 batches of its typhoid vaccine Typhim Vi after recent investigations found some syringes may have sub-potent antigen levels, the Medicines and Healthcare products Regulatory Agency (MHRA) says.
This article is viewable by subscribers only. To view this article, please select an option below.
|